Dr Lalchandani Labs Ltd (BSE: 541299) is a New Delhi, Delhi-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹6 Cr, it ranks #4,975 by market cap among the 6,197 Indian listed companies on FinBizNet, and #15 of 18 in Medical Diagnostic Centres. At ₹6.19 (as of 16 Nov 2026), the share price is 73.9% below its 52-week high of ₹23.69 and 6.5% above its 52-week low of ₹5.81. The share price is down 73.7% over one year and down 1.9% over three months.
| Current Price | ₹6.19 |
|---|---|
| Market Cap | ₹6 Cr |
| BSE Code | 541299 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 92.4 |
| Return on Equity | 4.28% |
| Return on Assets | -1.86% |
| 52-Week Range | ₹5.81 – ₹23.69 |
| 1-Year Price Change | -73.7% |
| 3-Month Price Change | -1.9% |
| Beta (1Y) | -0.55 |
| Headquarters | New Delhi, Delhi |
| Website | www.lalchandanipathlab.com |
Delivery averaged 78.3% of traded volume across 12 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Dr Lalchandani Labs Limited provides diagnostic and related healthcare tests and services in India. The company offers doctor consultation, pathology, radiology, hospital lab management, corporate health checkup, and blood bank services, as well as X-ray, TMT, ultrasound, 2D-echo, and medical fitness examinations. It also offers its products online. The company serves individual patients, hospitals and other healthcare providers, and corporate customers. Dr Lalchandani Labs Limited was founded in 1986 and is based in New Delhi, India.
1. B2B-This segment provides a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and other health conditions. 2. B2C-This segment provides a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and other health conditions. 3. Healthcare and Diagonis Services-This segment provides diagnostic and related healthcare tests and services. It offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing and patient diagnosis, as well as the prevention, monitoring, and treatment of disease and
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Dr Lalchandani Labs Ltd | ₹6 Cr | 92.4 | 4.28% | — | -73.7% |
Listed by market capitalisation. Ratios are shown for context only.
Dr Lalchandani Labs Ltd is trading at ₹6.19, with a market capitalisation of ₹6 Cr.
Dr Lalchandani Labs Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Dr Lalchandani Labs Ltd has a P/E of 92.4 and a return on equity of 4.28%.
Dr Lalchandani Labs Ltd is listed on the BSE under the scrip code 541299.
Dr Lalchandani Labs Ltd's share price is down 73.7% over one year and down 1.9% over three months. Its 52-week range is ₹5.81 to ₹23.69.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.